肠溶软胶囊市场规模、份额和成长分析（按产品类型、原材料、分销管道、应用和地区划分）- 产业预测（2026-2033 年）

预计到 2024 年，全球肠溶软胶囊市场规模将达到 25 亿美元，到 2025 年将达到 26 亿美元，到 2033 年将达到 35.9 亿美元，预测期（2026-2033 年）的复合年增长率为 4.1%。

全球肠溶软胶囊市场正经历强劲成长，其主要驱动因素包括消费者对预防保健益处的日益重视、人口老化以及慢性病和营养缺乏症的增加。肠溶软胶囊是一种将半固态和液体药物包裹在明胶基包衣中的产品。製药业的扩张以及在肠溶软胶囊中添加Omega-3脂肪酸进一步推动了市场需求。健康意识的增强提高了人们对膳食补充剂的接受度，从而进一步扩大了市场潜力。针对素食消费者的创新产品开发，例如由淀粉和植物来源成分製成的非明胶软胶囊，以及线上药局的兴起，也推动了市场成长。此外，无需用水即可服用的新型咀嚼片的开发预计也将进一步扩大肠溶软胶囊市场。

全球肠溶软胶囊市场驱动因素

全球肠溶软胶囊市场正经历显着成长，这主要归功于企业加大研发投入，旨在提高此类胶囊的生物利用度。主要行业参与者正在扩大产能，以满足日益增长的保健和营养补充剂需求。改进胶囊包衣技术对于巩固市场地位至关重要。此外，主要企业采用先进的生产技术，旨在降低复杂性、减少成本并简化药物开发流程。这些策略措施不仅提高了营运效率，也有助于提升肠溶软胶囊市场的整体生产力。

限制全球肠溶软胶囊市场发展的因素

全球肠溶软胶囊市场面临与胶囊长期稳定性相关的重大限制因素。消费者经常会遇到保存期限问题，尤其是在软胶囊长期储存的情况下。这给致力于提升产品保质期和化学稳定性的生产商带来了挑战，因为肠溶软胶囊的固有特性使得优化过程变得复杂。因此，维持这些胶囊的完整性和有效性方面的困难可能会阻碍其市场推广。总而言之，这些稳定性问题是肠溶软胶囊市场成长的一大障碍。

全球肠溶软胶囊市场趋势

全球肠溶软胶囊市场正经历转型，其主要驱动力是消费者对植物来源替代品的需求不断增长。这主要是由于人们对动物性产品的伦理和健康影响的认识日益提高。因此，製造商正致力于创新，开发适合纯素主义者的软胶囊，以植物来源材料取代传统的明胶包衣，以满足日益增长的健康和环保意识消费者的需求。这项转变不仅开闢了新的市场机会，也迫使现有企业重新思考其产品配方，标誌着肠溶软胶囊产业的重大变革。

目录

介绍

• 分析目的
• 分析范围
• 定义

分析方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特五力分析

关键市场考量因素

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场魅力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球肠溶软胶囊市场规模及按产品类型分類的复合年增长率（2026-2033 年）

• 明胶软胶囊
• 素食软胶囊

全球肠溶软胶囊市场规模及依原料分類的复合年增长率（2026-2033）

• A型明胶（猪皮）
• B型明胶（动物骨骼和皮肤）
• 鱼骨明胶
• 纤维素衍生物
• 淀粉材料

全球肠溶软胶囊市场规模及按分销管道分類的复合年增长率（2026-2033 年）

• 超级市场和大卖场
• 药房和药品商店
• 网路商家

全球肠溶软胶囊市场规模及按应用领域分類的复合年增长率（2026-2033 年）

• 制酸剂和肠道调节剂
• 抗发炎药
• 抗生素和抗菌药物
• 咳嗽和感冒药
• 保健品
• 维生素和营养补充剂
• 其他治疗用途

全球肠溶软胶囊市场规模及最终用户复合年增长率（2026-2033 年）

• 製药公司
• 营养保健品公司
• 药用化妆品公司
• 食品工业

全球肠溶软胶囊市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2025 年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市占率（2025 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 年比营收比较（2023-2025）

主要企业简介

• BASF股份公司（德国）
• Colorcon Inc.（美国）
• 富士胶囊株式会社（日本）
• 龙沙集团股份公司（瑞士）
• Now Health Group Inc.（美国）
• ProCaps集团（卢森堡）
• Super Spectrim（美国）
• 赛默飞世尔科技公司（美国）
• Key Developments
• 思锐医药股份有限公司 (中国)
• 软凝胶技术公司（美国）
• EuroCaps有限公司（英国）
• Geltec Pvt. Ltd.（印度）
• Captek Softgel International, Inc.（美国）
• Elnova Pharma（加拿大）
• 最佳配方（美国）
• Pharmavite LLC（美国）
• 罗宾逊製药公司（美国）

结论与建议

Global Enteric Softgel Market size was valued at USD 2.5 Billion in 2024 and is poised to grow from USD 2.6 Billion in 2025 to USD 3.59 Billion by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The global market for enteric softgel capsules, which feature gelatin-based coatings enclosing semi-solid and liquid medications, is experiencing robust growth driven by heightened consumer awareness of preventive medicine benefits, an aging population, and an uptick in chronic and nutrient deficiency illnesses. The expanding pharmaceutical industry and the incorporation of omega-3 oils into these capsules further contribute to market demand. As health consciousness rises, greater acceptance of dietary and nutritional supplements enhances market potential. Innovations catering to vegan consumers, such as non-gelatin softgels made from starch and plant-based sources, alongside the proliferation of e-commerce pharmacies, bolster growth. Additionally, novel chewable formulations that eliminate the need for water are expected to further enhance the enteric softgel market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteric Softgel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enteric Softgel Market Segments Analysis

Global Enteric Softgel Market is segmented by Product Type, Raw Material, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Gelatin Softgel Capsules and Vegetarian Softgel Capsules. Based on Raw Material, the market is segmented into Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones and Skin), Fish Bone Gelatin, Cellulose Derivatives and Starch Material. Based on Distribution Channel, the market is segmented into Supermarket and Hypermarket, Pharmacy and Drug store and Online Provider. Based on Application, the market is segmented into Antacid and Antiflatulent Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplements, Vitamin and Dietary Supplements and Other Therapeutic Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Food Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Enteric Softgel Market

The Global Enteric Softgel market is experiencing significant growth, primarily driven by increasing investments in research and development aimed at enhancing the bioavailability of these capsules. Key industry players are expanding production capacities to satisfy the rising demand for health and nutritional supplements. Efforts to improve capsule coating technology are essential for establishing a more robust market presence. Additionally, the implementation of advanced manufacturing techniques by leading companies focuses on minimizing complexity, lowering costs, and streamlining drug development processes. These strategic initiatives not only enhance business efficiency but also contribute to increased productivity in the enteric softgel segment of the market.

Restraints in the Global Enteric Softgel Market

The Global Enteric Softgel market faces significant constraints related to the stability of these capsules over time. Consumers often encounter issues with shelf-life, particularly when these softgels are stored beyond an extended period. This poses challenges for manufacturers seeking to enhance the shelf-life and chemical stability of their products, as the inherent characteristics of enteric softgels complicate the optimization process. As a result, the difficulties associated with maintaining the integrity and effectiveness of these capsules can hinder their widespread adoption in the market. Overall, these stability concerns represent a notable barrier to the growth of the enteric softgel segment.

Market Trends of the Global Enteric Softgel Market

The Global Enteric Softgel market is witnessing a transformative shift driven by the growing trend toward plant-based alternatives, as consumers increasingly adopt vegan lifestyles. This shift is primarily fueled by heightened awareness of the ethical and health-related implications of animal-derived products. As a result, manufacturers are innovating to develop vegan-friendly softgel capsules that replace traditional gelatin coatings with plant-based materials, catering to the rising demand from health-conscious and environmentally aware consumers. This transition not only opens new market opportunities but also compels established players to rethink their product formulations, marking a significant evolution in the enteric softgel landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Enteric Softgel Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Gelatin Softgel Capsules
• Vegetarian Softgel Capsules

Global Enteric Softgel Market Size by Raw Material & CAGR (2026-2033)

• Market Overview
• Type-A Gelatin (Pork Skin)
• Type-B Gelatin (Animal Bones and Skin)
• Fish Bone Gelatin
• Cellulose Derivatives
• Starch Material

Global Enteric Softgel Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Supermarket and Hypermarket
• Pharmacy and Drug store
• Online Provider

Global Enteric Softgel Market Size by Application & CAGR (2026-2033)

• Market Overview
• Antacid and Antiflatulent Preparations
• Anti-inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplements
• Vitamin and Dietary Supplements
• Other Therapeutic Applications

Global Enteric Softgel Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Food Industry

Global Enteric Softgel Market Size & CAGR (2026-2033)

• North America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • US
  • Canada
• Europe (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Raw Material, Distribution Channel, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Raw Material, Distribution Channel, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Capsule Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Now Health Group Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProCaps Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Super Spectrim (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Sirio Pharma Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soft Gel Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuroCaps Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geltec Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Captek Softgel International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elnova Pharma (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Formulations (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmavite LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Robinson Pharma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations